Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid merger concerns. The M&A-focused class action firm has recovered millions for shareholders.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), scrutinizing whether the home and alternate-site infusion therapy company's board has adequately protected shareholder interests, according to an announcement released in October 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, is spearheading the probe. The firm, which focuses heavily on mergers and acquisitions litigation, was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report and has previously recovered millions of dollars on behalf of investors in similar cases.
Read more Retail Investing Platforms Hit 41M Accounts After Record Summer →
Shareholder investigations of this nature typically arise when a company enters a merger, acquisition, or other significant corporate transaction that critics argue may undervalue shares or shortchange investors. While the announcement does not detail the specific transaction or conduct under review, such probes often precede formal class action filings if attorneys determine that shareholders were not adequately informed or compensated.
Option Care Health shareholders who believe they may have been harmed or who wish to learn more about their legal rights are encouraged to contact the firm directly. Investors generally face deadlines to participate in class action proceedings, making early engagement with legal counsel important for those seeking to preserve their options.
Continue reading at All Financial Services & Investing.
